Alzamend Neuro, Inc. (NasdaqCM: ALZN)
Health Care · Biotechnology · US
$1.30
-2.99% today · -44.7% 1Y
Alzamend Neuro, Inc. (NasdaqCM: ALZN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.27M and employs 6 people.
Over the last twelve months the share price has lost 44.7%, trading between 0.84 and 2.68.
Tweenvest scores Alzamend Neuro, Inc. across four factors: quality 35/100, value 20/100. Its strongest factor is quality.
ALZN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.27M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.31
- Dividend yield
- —
- Beta (5Y)
- 0.27
- 52-week high
- $2.68
- 52-week low
- $0.84
- Avg volume (3M)
- —
- Shares outstanding
- 4.83M
- Employees
- 6
- Next earnings
- —
About Alzamend Neuro, Inc.
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
- ISIN
- US02262M6057
- Founded
- 2016
- Listed since
- Jun 15, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Subgen AI AB (publ)OM: SUBGEN | $6.44M | Skr0.03 | +7.33% |
| XTL Biopharmaceuticals Ltd.TASE: XTLB | $6.41M | ₪0.02 | -6.25% |
| Theracryf PlcAIM: TCF | $6.38M | £0.00 | +2.94% |
| Moleculin Biotech, Inc.NasdaqCM: MBRX | $6.33M | $6.50 | +10.36% |
| Coegin Pharma ABNGM: COEGIN | $6.26M | Skr2.17 | -10.33% |
| COSCIENS Biopharma Inc.TSX: CSCI | $6.11M | CA$8.62 | +0.23% |
| Evogene Ltd.TASE: EVGN | $6.08M | ₪1.19 | -2.69% |
| Bio Green Med Solution, Inc.NasdaqCM: BGMS | $6.02M | $0.91 | +7.10% |
Figures last refreshed Oct 18, 2026.